Nancy Cocchiarella
Women's Health · Providence, RINPI 1295994069
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.0% of the total across 138 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations.
Across 138 payments — averaging $22.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$457
- Exeltis, USA Inc.$300
- Myovant Sciences Inc.$267
- AbbVie$225
- Sumitomo Pharma America, Inc.$207
- Agile Therapeutics, Inc.$202
- plus $1K from 17 others
What the payments were for
- Food & beverage$2,88494%
- Education$1856%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 13 | $457 |
| Exeltis, USA Inc. | 15 | $300 |
| Myovant Sciences Inc. | 15 | $267 |
| AbbVie | 10 | $225 |
| Sumitomo Pharma America, Inc. | 12 | $207 |
| Agile Therapeutics, Inc. | 9 | $202 |
| Mayne Pharma Commercial LLC | 8 | $194 |
| Myriad Women's Health, Inc. | 1 | $138 |
| Pfizer | 7 | $138 |
| Mylan Pharmaceuticals Inc. | 7 | $133 |
| Bayer | 6 | $114 |
| Scynexis, Inc. | 5 | $109 |
| Evofem Biosciences, Inc. | 6 | $107 |
| Therapeuticsmd, Inc. | 5 | $85 |
| Coopersurgical, Inc. | 4 | $79 |
| Sage Therapeutics, LLC | 3 | $70 |
| Daiichi Sankyo Inc. | 3 | $64 |
| Dexcom, Inc. | 2 | $50 |
| Medicem Inc. | 3 | $36 |
| Organon | 1 | $27 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
| Exact Sciences | 1 | $22 |
| Hologic Sales And Service, LLC | 1 | $21 |
How this compares
Too few women's health providers in Rhode Islandto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 17 | $1,262 |
| Estradiol | 17 | $714 |
| Hydrocortisone | 13 | $205 |
Paid to pharmacies, not to this prescriber.
Other women's health in Providence
- Jenny QuiltyProvidence$1K
- Nina MoneymakerProvidence$826
- Paige McCannProvidence$200
- Mary DromgooleProvidence$95
- Jacalyn FinertyProvidence$72
- Elizabeth RicciProvidence$41
- Patricia O'ConnellProvidence$24
- Teresa BertProvidence$21
- Amy CooperProvidence$17
- Laura CookProvidence$17
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.